Insider Buying: Spectral Medical Inc (TSE:EDT) Insider Buys 100,000 Shares of Stock

Spectral Medical Inc (TSE:EDT) insider Debra-Anne Foster purchased 100,000 shares of the business’s stock in a transaction on Tuesday, February 11th. The shares were acquired at an average price of C$0.38 per share, for a total transaction of C$37,500.00. Following the completion of the purchase, the insider now directly owns 234,855 shares of the company’s stock, valued at C$88,070.63.

Shares of TSE:EDT opened at C$0.75 on Friday. The company has a debt-to-equity ratio of 21.26, a current ratio of 4.24 and a quick ratio of 3.64. The firm has a market capitalization of $155.81 million and a PE ratio of -57.69. The firm’s 50-day moving average is C$0.75 and its two-hundred day moving average is C$0.55. Spectral Medical Inc has a 1 year low of C$0.30 and a 1 year high of C$0.85.

Spectral Medical (TSE:EDT) last issued its quarterly earnings results on Thursday, November 14th. The company reported C($0.01) earnings per share (EPS) for the quarter. The business had revenue of C$0.53 million for the quarter. Analysts expect that Spectral Medical Inc will post -0.06 EPS for the current fiscal year.

About Spectral Medical

Spectral Medical Inc focuses on the development and commercialization of treatment for septic shock in North America. The company markets Endotoxin Activity Assay, a rapid diagnostic test for the detection of components of gram negative bacterial cell wall in Europe and Canada; and Toraymyxin, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream in Europe, Canada, and Japan.

Read More: What is the S&P/TSX Index?

Receive News & Ratings for Spectral Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spectral Medical and related companies with MarketBeat.com's FREE daily email newsletter.